Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia.
1991 · Journal of Lipid Research · 72 citations
https://doi.org/10.1016/s0022-2275(20)41990-x
M
Mats Eriksson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
188
Papers
10.6K
Citations
44
h-index
112
i10-index
Mats Eriksson is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Cholesterol and Lipid Metabolism & Cancer, Lipids, and Metabolism. The author has an h-index of 44, co-authored 160 publications.
ORCID: 0000-0001-6481-5549Papers by this author
worksHNF1 and SREBP2 are important regulators of NPC1L1 in human liver
2010 · Journal of Lipid Research · 53 citations
https://doi.org/10.1194/jlr.m900274
HNF1α and SREBP2 are important regulators of NPC1L1 in human liver
2009 · Journal of Lipid Research · 49 citations
https://doi.org/10.1194/jlr.m900274-jlr200
Control of ACAT2 liver expression by HNF1
2005 · Journal of Lipid Research · 37 citations
https://doi.org/10.1194/jlr.m400450-jlr200
Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice
2022 · Oxford University Research Archive (ORA) (University of Oxford) · 19 citations
Evidence for a lack of regulatory importance of the 12 alpha-hydroxylase in formation of bile acids in man: an in vivo study.
1983 · Journal of Lipid Research · 17 citations
https://doi.org/10.1016/s0022-2275(20)37868-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat